See more : Progress Software Corporation (PRGS) Income Statement Analysis – Financial Results
Complete financial analysis of Nexus AG (NXU.DE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nexus AG, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Molecular Data Inc. (MKDTY) Income Statement Analysis – Financial Results
- Eucatex S.A. Indústria e Comércio (EUCA3.SA) Income Statement Analysis – Financial Results
- Okura Holdings Limited (1655.HK) Income Statement Analysis – Financial Results
- BioLargo, Inc. (BLGO) Income Statement Analysis – Financial Results
- Serko Limited (SKO.AX) Income Statement Analysis – Financial Results
Nexus AG (NXU.DE)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.nexus-ag.de
About Nexus AG
Nexus AG develops and sells software and hardware solutions, and provides IT services, primarily for customers in the health care system worldwide. It operates in two divisions, Healthcare Software and Healthcare Services. The company offers information systems, such as NEXUS/HIS and KIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/REHAB for rehabilitation facilities; ITR, a software for rehabilitation, clinics, and hotels with medical care; NEXUS/ARCHIVE and PEGASOS, an archiving and process management system; NEXUS/QM for quality management; NEXUS/INTEGRATION SERVER, an interface management; NEXUS/CLOUD IT, outsourcing solution; NEXUS/EPS, a software solution to supplement SAP personnel management, as well as process and HR consulting in the SAP environment; ifa systems, an ophthalmology software solution; Sophrona solutions, ophthalmology patients and referral program; and NEXUS/DIS, interdisciplinary diagnostic information system. Its information systems also comprise NEXUS/SWISSLAB, a laboratory information system; NEXUS/LAURIS for order communication in diagnostics; NEXUS/PATHOLOGY and NEXUS/CYTOLOGY for pathology and cytology institutes; dc-Pathos and dc-LabMan for pathology and cytology devices; NEXUS/RADIOLOGY, an information and image system for radiology wards and offices; NEXUs/CHILI, for PACS and teleradiology solutions; NEXUS/ASTRAIA for obstetrics and gynecology; NEXUS/SPECIAL DIAGNOSTICS and Clinic WinData for medical specialist diagnostics and device integration; NEXUS/HOME for senior citizen and nursing homes; NEXUS/OUTPATIENT CARE and Asebis, a homecare solution; NEXUS/PAT, an administration system for hospitals; and osoTEC for billing personal and other services. In addition, the company offers SINAPSI, highsystemNET, CREATIV OM, SEXTANT, Emed, NEXUS/EPD, NEXUS/AEMP, NEXUS/SPM, EuroSDS, RVS Software, NEXUS/VITA and TESIS VITA, and NEXUS/ESKULAP. NEXUS AG is headquartered in Donaueschingen, Germany.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 241.46M | 209.13M | 188.18M | 162.94M | 147.65M | 136.47M | 119.08M | 107.05M | 97.27M | 80.15M | 73.26M | 62.34M | 53.53M | 44.82M | 40.36M | 34.82M | 29.71M | 26.12M | 20.98M | 16.40M |
| Cost of Revenue | 175.49M | 32.67M | 29.08M | 21.35M | 17.66M | 18.91M | 14.31M | 11.89M | 10.54M | 10.83M | 9.30M | 7.34M | 5.27M | 8.33M | 4.39M | 3.30M | 2.67M | 2.82M | 0.00 | 0.00 |
| Gross Profit | 65.97M | 176.46M | 159.10M | 141.60M | 129.99M | 117.56M | 104.78M | 95.17M | 86.73M | 69.32M | 63.96M | 55.00M | 48.26M | 36.49M | 35.97M | 31.53M | 27.05M | 23.30M | 20.98M | 16.40M |
| Gross Profit Ratio | 27.32% | 84.38% | 84.54% | 86.90% | 88.04% | 86.14% | 87.99% | 88.90% | 89.17% | 86.48% | 87.30% | 88.22% | 90.15% | 81.42% | 89.11% | 90.54% | 91.03% | 89.19% | 100.00% | 100.00% |
| Research & Development | 44.60M | 40.70M | -2.53M | -3.01M | -3.85M | -4.13M | -5.06M | -5.44M | -5.29M | -4.69M | -4.51M | -4.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 9.93M | 8.30M | 7.85M | 7.22M | 7.91M | 5.45M | 4.17M | 3.24M | 4.12M | 3.49M | 2.97M | 2.74M | 0.00 | 0.00 | 0.00 | 4.40M | 0.00 | 0.00 | 17.06M | 15.07M |
| Selling & Marketing | 6.90M | 5.09M | 3.28M | 3.04M | 4.24M | 3.89M | 3.58M | 3.30M | 3.10M | 2.76M | 2.94M | 2.81M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 16.83M | 13.39M | 11.13M | 10.26M | 12.15M | 9.34M | 7.74M | 6.54M | 7.22M | 6.25M | 5.91M | 5.54M | 0.00 | 0.00 | 0.00 | 4.40M | 0.00 | 0.00 | 17.06M | 15.07M |
| Other Expenses | 576.00K | 135.52M | 126.53M | 117.14M | 106.98M | 93.00M | 83.60M | 77.56M | 70.33M | 54.81M | 50.81M | 44.74M | 44.04M | 32.76M | 33.99M | 869.00K | 26.05M | 22.87M | -2.41M | -1.09M |
| Operating Expenses | 44.99M | 148.91M | 135.12M | 124.39M | 115.28M | 102.33M | 91.34M | 84.10M | 77.55M | 61.06M | 56.72M | 50.29M | 44.04M | 32.76M | 33.99M | 5.26M | 26.05M | 22.87M | 14.65M | 13.98M |
| Cost & Expenses | 241.46M | 181.58M | 164.21M | 145.74M | 132.93M | 121.25M | 105.65M | 95.98M | 88.09M | 71.89M | 66.02M | 57.63M | 49.32M | 41.09M | 38.38M | 8.56M | 28.72M | 25.69M | 14.65M | 13.98M |
| Interest Income | 3.04M | 518.00K | 1.05M | 27.00K | 32.00K | 34.00K | 62.00K | 70.00K | 149.00K | 211.00K | 221.00K | 392.00K | 403.00K | 210.00K | 308.00K | 553.00K | 689.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.92M | 1.04M | 1.05M | 329.00K | 598.00K | 171.00K | 103.00K | 56.00K | 87.00K | 79.00K | 60.00K | 13.00K | 121.00K | 632.00K | 56.00K | 26.00K | 15.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 18.52M | 16.50M | 16.66M | 16.73M | 16.50M | 11.53M | 10.40M | 10.09M | 9.24M | 7.01M | 7.08M | 6.50M | 6.41M | 5.72M | 5.42M | 4.83M | 4.14M | 3.72M | 3.50M | 3.88M |
| EBITDA | 53.43M | 44.81M | 40.77M | 36.69M | 33.97M | 26.63M | 23.69M | 21.05M | 18.95M | 15.33M | 13.84M | 12.35M | 10.94M | 9.05M | 7.71M | 6.71M | 5.83M | 4.14M | 9.84M | 6.30M |
| EBITDA Ratio | 22.13% | 21.52% | 21.75% | 20.83% | 21.19% | 19.55% | 20.01% | 19.74% | 19.62% | 19.31% | 19.79% | 19.64% | 20.86% | 21.55% | 19.11% | 19.27% | 19.61% | 15.86% | 46.88% | 38.41% |
| Operating Income | 24.77M | 28.49M | 24.27M | 17.21M | 27.10M | 15.18M | 13.32M | 10.93M | 9.64M | 8.03M | 6.92M | 5.40M | 4.22M | 3.73M | -2.63M | 1.33M | 994.00K | 429.00K | 6.34M | 2.42M |
| Operating Income Ratio | 10.26% | 13.62% | 12.90% | 10.56% | 18.35% | 11.12% | 11.18% | 10.21% | 9.91% | 10.02% | 9.45% | 8.67% | 7.88% | 8.32% | -6.52% | 3.81% | 3.35% | 1.64% | 30.21% | 14.75% |
| Total Other Income/Expenses | 8.23M | 9.51M | 7.39M | 4.85M | -582.00K | -252.00K | -37.00K | -18.00K | -28.00K | 212.00K | 158.00K | 468.00K | 305.00K | -422.00K | 60.00K | 528.00K | 683.00K | 0.00 | -5.92M | -2.54M |
| Income Before Tax | 32.99M | 27.26M | 23.06M | 19.59M | 16.86M | 14.93M | 13.28M | 10.91M | 9.61M | 8.24M | 7.08M | 5.82M | 4.64M | 3.31M | 2.23M | 1.85M | 1.68M | 0.00 | 422.00K | -119.00K |
| Income Before Tax Ratio | 13.66% | 13.04% | 12.25% | 12.02% | 11.42% | 10.94% | 11.15% | 10.19% | 9.88% | 10.28% | 9.66% | 9.34% | 8.66% | 7.38% | 5.53% | 5.32% | 5.64% | 0.00% | 2.01% | -0.73% |
| Income Tax Expense | 9.20M | 7.49M | 5.60M | 4.50M | 4.74M | 3.93M | 3.13M | 2.30M | 1.84M | 135.00K | -142.00K | 61.00K | -59.00K | -230.00K | 129.00K | 321.00K | 480.00K | -96.00K | 333.00K | 537.00K |
| Net Income | 24.03M | 19.35M | 17.15M | 14.92M | 10.84M | 10.92M | 9.83M | 8.15M | 7.58M | 8.28M | 7.60M | 6.13M | 4.70M | 3.54M | 2.10M | 1.53M | 1.16M | 525.00K | 262.00K | -470.00K |
| Net Income Ratio | 9.95% | 9.25% | 9.12% | 9.15% | 7.34% | 8.00% | 8.26% | 7.61% | 7.80% | 10.33% | 10.37% | 9.83% | 8.77% | 7.89% | 5.21% | 4.40% | 3.91% | 2.01% | 1.25% | -2.87% |
| EPS | 1.39 | 1.21 | 1.09 | 0.95 | 0.69 | 0.69 | 0.63 | 0.52 | 0.49 | 0.55 | 0.48 | 0.42 | 0.33 | 0.25 | 0.15 | 0.11 | 0.08 | 0.05 | 0.02 | -0.04 |
| EPS Diluted | 1.39 | 1.21 | 1.09 | 0.95 | 0.69 | 0.69 | 0.62 | 0.52 | 0.48 | 0.55 | 0.48 | 0.42 | 0.33 | 0.25 | 0.15 | 0.11 | 0.08 | 0.05 | 0.02 | -0.04 |
| Weighted Avg Shares Out | 17.29M | 15.96M | 15.75M | 15.75M | 15.73M | 15.73M | 15.72M | 15.73M | 15.62M | 15.07M | 15.06M | 14.41M | 14.21M | 13.92M | 13.80M | 13.80M | 13.79M | 10.50M | 13.72M | 12.29M |
| Weighted Avg Shares Out (Dil) | 17.25M | 16.01M | 15.75M | 15.75M | 15.73M | 15.73M | 15.74M | 15.75M | 15.66M | 15.07M | 15.07M | 14.41M | 14.21M | 13.92M | 13.80M | 13.80M | 13.79M | 10.50M | 13.72M | 12.29M |
Source: https://incomestatements.info
Category: Stock Reports